Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1654
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPARRA, E. R.-
dc.contributor.authorFALZONI, R.-
dc.contributor.authorCAPELOZZI, V. L.-
dc.date.accessioned2013-08-12T17:46:14Z-
dc.date.available2013-08-12T17:46:14Z-
dc.date.issued2012-
dc.identifier.citationBRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, v.45, n.7, p.665-675, 2012-
dc.identifier.issn0100-879X-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1654-
dc.description.abstractIn this study, we demonstrated the importance of telomerase protein expression and determined the relationships among telomerase, endothelin-1 (ET-1) and myofibroblasts during early and late remodeling of parenchymal and vascular areas in usual interstitial pneumonia (UIP) using 27 surgical lung biopsies from patients with idiopathic pulmonary fibrosis (IPF). Telomerase+, myofibroblasts alpha-SMA+, smooth muscle cells caldesmon+, endothelium ET-1+ cellularity, and fibrosis severity were evaluated in 30 fields covering normal lung parenchyma, minimal fibrosis (fibroblastic foci), severe ( mural) fibrosis, and vascular areas of UIP by the point-counting technique and a semiquantitative score. The impact of these markers was determined in pulmonary functional tests and follow-up until death from IPF. Telomerase and ET-1 expression was significantly increased in normal and vascular areas compared to areas of fibroblast foci. Telomerase and ET-1 expression was inversely correlated with minimal fibrosis in areas of fibroblast foci and directly associated with severe fibrosis in vascular areas. Telomerase activity in minimal fibrosis areas was directly associated with diffusing capacity of the lung for oxygen/alveolar volume and ET-1 expression and indirectly associated with diffusing capacity of the lungs for carbon monoxide and severe fibrosis in vascular areas. Cox proportional hazards regression revealed a low risk of death for females with minimal fibrosis displaying high telomerase and ET-1 expression in normal areas. Vascular dysfunction by telomerase/ET-1 expression was found earlier than vascular remodeling by myofibroblast activation in UIP with impact on IPF evolution, suggesting that strategies aimed at preventing the effect of these mediators may have a greater impact on patient outcome.-
dc.description.sponsorshipCNPq-
dc.description.sponsorshipFAPESP [2008/53022-3]-
dc.language.isoeng-
dc.publisherASSOC BRAS DIVULG CIENTIFICA-
dc.relation.ispartofBrazilian Journal of Medical and Biological Research-
dc.rightsopenAccess-
dc.subjectIdiopathic pulmonary fibrosis-
dc.subjectVascular activity-
dc.subjectImmunohistochemistry-
dc.subjectSurvival-
dc.subject.othertelomerase activity-
dc.subject.otherlung-
dc.subject.othercells-
dc.subject.otherdifferentiation-
dc.subject.otherfibroblasts-
dc.subject.otherexpression-
dc.subject.otherproliferation-
dc.subject.otherendothelin-1-
dc.subject.othermetabolism-
dc.subject.otherinduction-
dc.titleVascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance-
dc.typearticle-
dc.rights.holderCopyright ASSOC BRAS DIVULG CIENTIFICA-
dc.identifier.doi10.1590/S0100-879X2012007500066-
dc.identifier.pmid22527129-
dc.subject.wosBiology-
dc.subject.wosMedicine, Research & Experimental-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.description.beginpage665-
hcfmusp.description.endpage675-
hcfmusp.description.issue7-
hcfmusp.description.volume45-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000305839600015-
hcfmusp.origem.id2-s2.0-84864123702-
hcfmusp.origem.idSCIELO:S0100-879X2012000700015-
hcfmusp.publisher.citySAO PAULO-
hcfmusp.publisher.countryBRAZIL-
hcfmusp.relation.referenceAbraham DJ, 1997, AM J PATHOL, V151, P831-
hcfmusp.relation.referenceAmerican Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias, 2002, AM J RESP CRIT CARE, V165, P277-
hcfmusp.relation.referenceBattistini B, 1998, PULM PHARMACOL THER, V11, P79, DOI 10.1006/pupt.1998.0148-
hcfmusp.relation.referenceCOUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900-
hcfmusp.relation.referenceDESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090-
hcfmusp.relation.referenceElias JA, 1992, PULMONARY FIBROBLAST, P295-
hcfmusp.relation.referenceGIAID A, 1991, AM J RESP CELL MOL, V4, P50-
hcfmusp.relation.referenceGreider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.biochem.65.1.337-
hcfmusp.relation.referenceGreider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90-
hcfmusp.relation.referenceGribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836-
hcfmusp.relation.referenceGUIDRY C, 1991, J CELL BIOL, V115, P873, DOI 10.1083/jcb.115.3.873-
hcfmusp.relation.referenceHaendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9-
hcfmusp.relation.referenceHsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST-
hcfmusp.relation.referenceLiu TJ, 2002, AM J RESP CELL MOL, V26, P534-
hcfmusp.relation.referenceMinamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001-
hcfmusp.relation.referenceNozaki Y, 2000, AM J RESP CELL MOL, V23, P460-
hcfmusp.relation.referenceParra ER, 2005, LUNG, V183, P291, DOI 10.1007/s00408-004-2542-z-
hcfmusp.relation.referenceParra ER, 2007, THORAX, V62, P428, DOI 10.1136/thx.2006.062687-
hcfmusp.relation.referencePHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953-
hcfmusp.relation.referenceQuanjer P H, 1993, Eur Respir J Suppl, V16, P5-
hcfmusp.relation.referenceRosenberger S, 2007, J BIOL CHEM, V282, P6126, DOI 10.1074/jbc.M610529200-
hcfmusp.relation.referenceSaleh D, 1997, AM J RESP CELL MOL, V16, P187-
hcfmusp.relation.referenceSarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836-
hcfmusp.relation.referenceSavoysky E, 1996, BIOCHEM BIOPH RES CO, V226, P329, DOI 10.1006/bbrc.1996.1356-
hcfmusp.relation.referenceSelman M, 2001, ANN INTERN MED, V134, P136-
hcfmusp.relation.referenceSerini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543-
hcfmusp.relation.referenceShichiri M, 1997, ENDOCRINOLOGY, V138, P4584, DOI 10.1210/en.138.11.4584-
hcfmusp.relation.referenceTomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809-
hcfmusp.relation.referenceWaisberg DR, 2010, HUM PATHOL, V41, P385, DOI 10.1016/j.humpath.2009.08.019-
hcfmusp.relation.referenceZhang HY, 1996, AM J PATHOL, V148, P527-
hcfmusp.relation.referenceZhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipCNPq-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.citation.scopus2-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPT
Departamento de Patologia - FM/MPT

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC


Files in This Item:
File Description SizeFormat 
art_PARRA_Vascular_dysfunction_by_myofibroblast_activation_in_patients_with_2012.PDFpublishedVersion (English)4.46 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.